Clinical Trials Directory

Trials / Completed

CompletedNCT01574144

REducing 30-day ADMIssions in posT-discharge Subjects (READMIT)

Observational Study of Reducing 30-day Admissions in Post-discharge Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this observational study is to collect and characterize multiple physiologic data from a broad subset of subjects with acute heart failure (HF) Changes in physiologic data are expected to correlate with 30-day readmission rates in this population

Detailed description

This is a multi-center, non-randomized feasibility study aimed at obtaining data from systolic and diastolic HF subjects in the hospital, with continued monitoring using an external wearable monitor for up to 4 weeks post-hospital-discharge. Data will be collected during the hospital stay and at in office follow-up visits at 1 week and 1 month post-hospital discharge The data will help generate hypotheses and aid in determining whether development of a detection algorithm for acute heart failure decompensation is feasible. Due to the feasibility nature of this study there is no minimum required sample size but it is anticipated that the study will enroll up to 100 subjects from seven (7) study sites in the United States and one (1) study site in Australia The study objectives are: * Collect and characterize physiologic data from subjects with acute decompensated heart failure. * Characterization of data related to health care utilizations within 30-days Post-discharge * Correlation between patch monitor collected data and inpatient clinical data * Correlation between patch monitor data and other clinical data collected after patient discharge (30-60 days)

Conditions

Interventions

TypeNameDescription
DEVICEAVIVO™ PiiX Patch Monitor SystemExternal monitoring for 30 days post-discharge.

Timeline

Start date
2012-04-01
Primary completion
2013-04-01
Completion
2013-08-01
First posted
2012-04-10
Last updated
2022-12-30
Results posted
2018-10-29

Locations

8 sites across 2 countries: United States, Australia

Source: ClinicalTrials.gov record NCT01574144. Inclusion in this directory is not an endorsement.